SG-1827

N/A

Report date: 2024/11/27 16:52:17

Base Information

Drug NameSG-1827
Drug Alias NameSG1827SG-1827
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionCluster of differentiation 80 modulators
TargetsCluster of differentiation 80
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesHangzhou Shangjian Biotechnology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesHangzhou Shangjian Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A